Locations
San Francisco, CA, USA · South San Francisco, CA, USA
industry
Biotechnology · DeepTech
Size
11-50 employees
Stage
Series A
founded in
2022
Moonwalk Biosciences is a pioneering genomic medicine startup focused on developing precision epigenetic therapeutics. The company leverages deep epigenomic insights to discover and develop therapies aimed at returning cells to their healthy state, particularly targeting cardiometabolic and obesity-related diseases. With a unique end-to-end epigenetic discovery platform, Moonwalk utilizes advanced AI for predicting epigenetic targets and employs a broad range of epigenetic engineering tools. Their innovative approach positions them as leaders in the field, enabling the identification of novel therapeutic targets and the development of effective treatments informed by comprehensive causal biology.
Something looks off?On-site & Remote